Tomáš Reigl

2017

• Bystry, V.; Reigl, T; Krejci, A; Demko, M; Hanakova, B; Grioni, A; Knecht, H; Schlitt, M.; Dreger, P; Sellner, L;Herrmann, D; Pingeon, M; Boudjoghra, M; Rijntjes, J; Pott, C; Langerak, A W; Groenen P. J; Davi, F; Brüggemann, M; Darzentas, N, 2017: ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS data. 33(3), p. 435 - 437
• Sellner, L; Bruggemann, M; Schlitt, M; Knecht, H; Herrmann, D; Reigl, T; Krejci, A; Bystry, V; Darzentas, N; Rieger, M; Dietrich, S; Luft, T; Ho, AD; Kneba, M; Dreger, P, 2017: GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses. BONE MARROW TRANSPLANTATION 52(4), p. 544 - 551, doi: 10.1038/bmt.2016.305
• Pal, K; Bystry, V; Reigl, T; Demko, M; Krejci, A; Touloumenidou, T; Stalika, E; Tichy, B; Ghia, P; Stamatopoulos, K; Pospisilova, S; Malcikova, J; Darzentas, N, 2017: GLASS: assisted and standardized assessment of gene variations from Sanger sequence trace data. BIOINFORMATICS 33(23), p. 3802 - 3804, doi: 10.1093/bioinformatics/btx423
• Roy, A; Bystry, V; Bohn, G; Goudevenou, K; Reigl, T; Papaioannou, M; Krejci, A; O´Byrne, S; Chaidos, A; Grioni, A; Darzentas, N; Roberts, IAG; Karadimitris, A, 2017: High resolution IgH repertoire analysis reveals fetal liver as the likely origin of life-long, innate B lymphopoiesis in humans. CLINICAL IMMUNOLOGY 183, p. 8 - 16, doi: 10.1016/j.clim.2017.06.005
• Knecht, H; Kotrova, M; Reigl, T; Krejci, A; Herrmann, D; Schwarz, M; Bystry, V; Darzentas, N; Bruggemann, M, 2017: T-CELL RECEPTOR. REPERTOIRE CHARACTERISTICS IN RELAPSED/REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA ON BLINATUMOMAB TREATMENT. HAEMATOLOGICA 102, p. 329 - 330

2016

• Grioni, A; Fazio, G; Reigl, T; Rigamonti, S; Bystry, V; Songia, S; Biondi, A; Darzentas, N; Cazzaniga, G, 2016: A PLATFORM FOR DETECTION OF FUSION GENES IN ALL FROM TARGET CAPTURE NEXT- GENERATION SEQUENCING OF DNA AND RNA. HAEMATOLOGICA 101, p. 26 - 27
• Sellner, L; Bruggemann, M; Schlitt, M; Knecht, H; Herrmann, D; Reigl, T; Krejci, A; Bystry, V; Darzentas, N; Rieger, M; Dietrich, S; Zenz, T; Ho, AD; Kneba, M; Dreger, P, 2016: Graft-versus-leukemia effects in T-prolymphocytic leukemia: evidence from minimal residual disease kinetics and T cell receptor repertoire analyses. ONCOLOGY RESEARCH AND TREATMENT 39, p. 78 - 78
• Sellner, L; Bruggemann, M; Schlitt, M; Knecht, H; Herrmann, D; Reigl, T; Krejci, A; Bystry, V; Darzentas, N; Rieger, M; Dietrich, S; Zenz, T; Ho, AD; Kneba, M; Dreger, P, 2016: Graft-versus-leukemia effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses. BONE MARROW TRANSPLANTATION 51, p. S68 - S69

2015

• Sellner, L; Dreger, P; Schlitt, M; Knecht, H; Herrmann, D; Reigl, T; Krejci, A; Bystry, V; Darzentas, N; Rieger, M; Dietrich, S; Zenz, T; Ho, AD; Kneba, M; Brueggemann, M, 2015: T-Prolymphocytic Leukemia Is Sensitive to Polyclonal T Cell-Derived Graft-Versus-Leukemia Effects: Evidence from Minimal Residual Disease Kinetics and TCR Repertoire Diversity Analyses. BLOOD 126(23)

• Vývoj modulární bioinformatické platformy pro analýzu dat získaných sekvenováním nové generace, , 2019 - 2021
• Expression and function of activation-induced cytidine deaminase splice variants in normal B cell physiology and chronic lymphocytic leukemia (3SGA5792), Jihomoravský kraj, 2013 - 2016
• Functional and structural changes of microRNAs in lymphoproliferative malignancies and their impact on prognosis and prediction of therapy response (NT11218), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2010 - 2015
• NGS-PTL - Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia (306242), Evropská unie, 2012 - 2015
• SuPReMMe - Podpora profesního růstu a mezinárodní integrace výzkumných týmů v oblasti molekulární medicíny (CZ.1.07/2.3.00/20.0045), Ministerstvo školství, mládeže a tělovýchovy ČR, 2011 - 2014
• Real-time PCR soupravy pro diagnostiku v onkologii (FR-TI2/254), Ministerstvo průmyslu a obchodu ČR, 2010 - 2013
• Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies (MSM0021622430), Ministerstvo školství, mládeže a tělovýchovy ČR, 2007 - 2013
• Involvement of nuclear HMGB proteins in sensitizing of human cells to anticancer drugs inhibiting DNA topoizomerases (GAP301/10/0590), Czech Science Foundation - Standard Grants, 2010 - 2012
• Analysis of changes in genome and its expression in chronic lymphocytic leukemia patients during the disease development (NS10439), Ministry of Health - Departmental Programme of Research and Development (2008-2011), 2009 - 2011